Alzheimer's Disease-Related Dementias Summit 2016: National research priorities.
Corriveau, Roderick A. PhD; Koroshetz, Walter J. MD; Gladman, Jordan T. PhD; Jeon, Sophia PhD; Babcock, Debra MD, PhD; Bennett, David A. MD; Carmichael, S. Thomas MD, PhD; Dickinson, Susan L.-J. MSGC; Dickson, Dennis W. MD; Emr, Marian; Fillit, Howard MD; Greenberg, Steven M. MD, PhD; Hutton, Michael L. PhD; Knopman, David S. MD; Manly, Jennifer J. PhD; Marder, Karen S. MD, MPH; Moy, Claudia S. PhD; Phelps, Creighton H. PhD; Scott, Paul A. PhD; Seeley, William W. MD; Sieber, Beth-Anne PhD; Silverberg, Nina B. PhD; Sutherland, Margaret L. PhD; Taylor, Angela; Torborg, Christine L. PhD; Waddy, Salina P. MD; Gubitz, Amelie K. PhD; Holtzman, David M. MD
89(23):2381-2391, December 05, 2017.
(Format: HTML, PDF)
Goal 1 of the National Plan to Address Alzheimer's Disease is to prevent and effectively treat Alzheimer disease and Alzheimer disease-related dementias by 2025. To help inform the research agenda toward achieving this goal, the NIH hosts periodic summits that set and refine relevant research priorities for the subsequent 5 to 10 years. This proceedings article summarizes the 2016 Alzheimer's Disease-Related Dementias Summit, including discussion of scientific progress, challenges, and opportunities in major areas of dementia research, including mixed-etiology dementias, Lewy body dementia, frontotemporal degeneration, vascular contributions to cognitive impairment and dementia, dementia disparities, and dementia nomenclature.
(C) 2017 American Academy of Neurology